COVID-19 Therapeutic and Prevention

Affiliations

¹ MEФI, IRD, Aix Marseille Univ, AP-HM, Marseille, France; IHU-Méditerranée Infection, Marseille, France. Electronic address: didier.raoult@gmail.com.
² Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
³ University of Catania, Department of Biomedical and Biotechnological Sciences, Biological Tower, Third floor -Est Tower, Catania, Italy.
⁴ MEФI, IRD, Aix Marseille Univ, AP-HM, Marseille, France; IHU-Méditerranée Infection, Marseille, France.

Editorial

Didier Raoult et al. Int J Antimicrob Agents. 2020 Apr.

. 2020 Apr;55(4):105937.

doi: 10.1016/j.ijantimicag.2020.105937. Epub 2020 Mar 7.

¹ MEФI, IRD, Aix Marseille Univ, AP-HM, Marseille, France; IHU-Méditerranée Infection, Marseille, France. Electronic address: didier.raoult@gmail.com.
² Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
³ University of Catania, Department of Biomedical and Biotechnological Sciences, Biological Tower, Third floor -Est Tower, Catania, Italy.
⁴ MEФI, IRD, Aix Marseille Univ, AP-HM, Marseille, France; IHU-Méditerranée Infection, Marseille, France.

No abstract available

References

1. . Coronavirus: keep sharing research. Nature. 2020;578(7793):7. - PubMed
1. Colson P., Rolain J.M., Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020 Feb 15 - PMC - PubMed
1. Colson P., Rolain J.M., Lagier J.C., Brouqui P., Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 press. - PMC - PubMed